Clinical trials
Cancer (With or Without Metastasis) clinical trials
Below are recruiting cancer (with or without metastasis) clinical trials, each written for real people, not researchers. We’re tracking 13,069 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06482086RecruitingPhase 2
Using tumor models to guide drug choice for advanced thyroid cancer
This trial tests whether growing your tumor cells in a lab (as organoids) can help doctors pick the best drugs for advanced thyroid cancer that is hard to remove surgically. It's for people with different thyroid cancer types who have tumors growing outside the thyroid or into nearby areas.
Chengdu, SichuanAges 18 years+ - NCT06718530Recruiting
Finding early markers for liver cancer in people with chronic liver disease
This study looks for substances in your blood and immune system that could help doctors find liver cancer earlier. It is for people with liver cancer caused by chronic liver problems like hepatitis C, cirrhosis, or scarring.
Aviano, PordenoneAges 18 years+ - NCT06718205RecruitingPhase 2
Nimotuzumab plus immunotherapy and chemo for esophageal cancer
This study tests a new combination of drugs for advanced esophageal cancer. It adds an antibody (nimotuzumab) and an immunotherapy (sintilimab) to standard chemotherapy, aiming to improve how well treatment works.
Zhengzhou, HenanAges 18–75 - NCT06718153Recruiting
Using protein tests to diagnose liver cancer types
This trial uses special stains on tumor tissue to find genetic changes in liver cancer cells. It may help doctors better diagnose and classify the type of liver cancer you have.
BolognaAges 18 years+ - NCT07588386Recruiting
Early Colonoscopy After Low Rectal Cancer Surgery
This study tests whether doing a colonoscopy (camera exam of the colon) early after surgery for low rectal cancer helps catch a serious complication called anastomotic leakage—when the surgical connection between bowel segments breaks down. Early detection might help prevent severe infections and improve outcomes.
Nanchong, SichuanAges 18–80 - NCT07587086Recruiting
PET/MR scan for breast cancer using fluorocholine
This study uses a special imaging scan (PET/MR) with a tracer called fluorocholine to see if it can help evaluate breast cancer before treatment or before surgery. It is for women who are newly diagnosed with breast cancer and will either have chemotherapy before surgery or go straight to surgery.
Taipei, TaiwanAges 25–75 - NCT07593092RecruitingPhase 1
Testing new cancer immunotherapy for advanced ovarian cancer
This study tests two new experimental drugs (XmAb541 and XmAb808) designed to fight advanced ovarian cancer by activating your immune system. You'll be closely monitored to see how safe the drugs are and how your body tolerates them.
Lake Success, New YorkAges 18 years+ - NCT07593248Recruiting
Real-World Lung Cancer Outcomes With Targeted Drug Therapy in China
This study looks at how well patients with early-stage lung cancer (that has been surgically removed) do when treated with a targeted drug called EGFR-TKI to prevent cancer from coming back. Researchers will track actual patient outcomes in China from 2023 to 2026.
BeijingAges 18 years+ - NCT07590024RecruitingPhase 3
Personalized Cancer Treatment Guidance for Nasopharyngeal Cancer
This trial tests whether a special analysis of blood markers and imaging scans can help doctors choose the best combination of chemotherapy and radiation for nasopharyngeal cancer. The goal is to improve outcomes by tailoring treatment to each patient's specific cancer characteristics.
Beijing, Beijing MunicipalityAges 18–65 - NCT07591389Recruiting
Radon Testing Education for Mothers of Young Children
This study tests ways to encourage mothers to test their homes for radon, a colorless gas that can build up indoors and pose health risks. Researchers want to learn how to help families protect their young children's health.
Bismarck, North DakotaAges 18 years+ - NCT07586384Recruiting
Single-Port vs Standard Laparoscopic Surgery for Stomach Cancer
This trial compares two minimally invasive surgical approaches for early-stage stomach cancer affecting the upper portion. Researchers want to see if a newer single-port technique (using one small incision) works as well as traditional laparoscopic surgery (using multiple small incisions) and may cause less pain or faster recovery.
Wenzhou, ZhejiangAges 18–80 - NCT07588737Recruiting
AI-Guided Recovery Support After Lung Cancer Surgery
This study uses artificial intelligence and a smartphone app to help monitor your recovery after lung cancer surgery. The goal is to track your symptoms and provide personalized guidance to support your healing and overall well-being.
Guangzhou, GuangdongAges 18–80 - NCT07591428Recruiting
Reducing risky drinking to prevent cancer
This study tests a program to help people who drink alcohol regularly cut back on high-risk drinking. The goal is to reduce cancer risk by changing drinking habits.
Tulsa, OklahomaAges 18–120 - NCT07586319Enrolling by invitation
Surgery to improve survival in early-stage spread breast cancer
This study tests whether surgery to remove cancer spots can help people with breast cancer that has spread to a few places live longer. You would receive standard cancer medicines plus surgery if you qualify.
Lahore, Punjab ProvinceAges 18 years+ - NCT07594431RecruitingPhase 2
New radiation therapy for cancer that has spread to the body
This study tests a newer radiation technique called LATTICE radiotherapy compared to standard radiation for treating cancer tumors that have spread to other parts of the body. The goal is to see if the new approach works better and causes fewer side effects.
Palo Alto, CaliforniaAges 12 years+ - NCT07586891Recruiting
Low-Branched-Chain Amino Acid Diet With Immunotherapy for Stage III Melanoma
This trial tests whether a special diet low in certain amino acids (building blocks of protein), combined with an immune-boosting antibody drug, can safely shrink stage III melanoma that has spread to lymph nodes. The goal is to see if this combination works better than standard treatment.
Xi'anAges 18–75 - NCT07591571Recruiting
Digital support program for newly diagnosed pancreatic cancer
This study tests a digital support program led by community health workers for people recently diagnosed with pancreatic adenocarcinoma (a type of pancreatic cancer). The program aims to help patients navigate their diagnosis and treatment.
Loma Linda, CaliforniaAges 1.5 years+ - NCT07590804Recruiting
Plant-Based Diet Study for Blood Cell Cloning
This study tests whether eating more plant-based whole foods can help people with clonal hematopoiesis (a condition where blood cells grow from a single mutated cell). Researchers want to understand if dietary changes affect this condition and collect health information over time.
Basking Ridge, New JerseyAges 18 years+ - NCT07591649RecruitingPhase 1/Phase 2
NK cells for high-risk blood cancers before transplant
This study tests a new type of immune cell therapy (called AdaptNK cells) for patients with high-risk myeloid diseases (blood cancers affecting bone marrow cells) who are preparing for a stem cell transplant. The goal is to help control the cancer and prepare your body for the transplant.
Minneapolis, MinnesotaAges 18 years+ - NCT07586215Recruiting
HER2-PET imaging to predict response to T-DXd in advanced breast cancer
This study is testing whether a special PET scan (HER2-PET) can help predict how well the drug T-DXd (also known as Enhertu) might work for your breast cancer. T-DXd is a targeted therapy that delivers chemotherapy directly to cancer cells with certain markers. The trial will check if the scan can identify which patients are more likely to benefit, which could help personalize treatment.
ShanghaiAges 18 years+ - NCT07586904RecruitingEarly Phase 1
New Immunotherapy Combination for Advanced Melanoma
This trial tests a combination of two drugs (cadonilimab and interferon) given before surgery to treat advanced melanoma that has spread to nearby lymph nodes or one distant site. The goal is to shrink tumors and improve chances of successful surgery and long-term survival.
Xi'anAges 18–75 - NCT06645691RecruitingPhase 2
Heart and metabolic imaging study using a special MRI scan
This study tests a new MRI method that uses a safe, natural substance (pyruvate) to take detailed pictures of the heart and metabolism. It may help doctors better understand heart disease, diabetes, and related conditions.
SingaporeAges 21–99 - NCT06720883Recruiting
Robot-assisted surgery for bile duct cancer
This study tests whether robot-assisted surgery is safe and effective for people with perihilar cholangiocarcinoma (a type of bile duct cancer). It may be a good fit for patients whose cancer has not spread and who are healthy enough for major surgery.
PadovaAges 18 years+ - NCT06720064Recruiting
Chlorhexidine dressing care for port and central catheters in children
This trial tests whether a special care bundle with a germ-killing dressing can reduce infections in children with port or central line catheters. It may help keep your child safer during treatment.
IzmirAges 1–17
Hear when a new Cancer (With or Without Metastasis) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for cancer (with or without metastasis)?
- Yes. Clin2 currently lists 13,069 recruiting cancer (with or without metastasis) studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a cancer (with or without metastasis) trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a cancer (with or without metastasis) trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
- Breast Cancer Early Stage Breast Cancer (Stage 1-3)
- Non Small Cell Lung Cancer
- Liver Metastasis Colon Cancer
- Gastric Cancer, Gastroesophageal Junction Cancer
- Lung Cancer Non-Small Cell Cancer (NSCLC)
- Colorectal Cancer Liver Metastasis
- Breast Cancer (Triple Negative Breast Cancer (TNBC))
- Leptomeningeal Metastasis of Breast Cancer
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.